[HTML][HTML] Hepatitis C virus risk among young people who inject drugs
Background Injection drug use (IDU) is the leading risk factor for hepatitis C virus (HCV)
transmission in the US While the general risk factors for HCV transmission are known, there …
transmission in the US While the general risk factors for HCV transmission are known, there …
[HTML][HTML] Hepatitis C transmission in young people who inject drugs: insights using a dynamic model informed by state public health surveillance
Increasing injection of heroin and prescription opioids have led to increases in the incidence
of hepatitis C virus (HCV) infections in US young adults since the early 2000s. How best to …
of hepatitis C virus (HCV) infections in US young adults since the early 2000s. How best to …
Drug use-related stigma, safer injection norms, and hepatitis C infection among a network-based sample of young people who inject drugs
Background Identifying risk for hepatitis C (HCV) infection is important for understanding
recent increases in HCV incidence among young people who inject drugs (PWID) in …
recent increases in HCV incidence among young people who inject drugs (PWID) in …
[HTML][HTML] Gaps in HCV knowledge and risk behaviors among young suburban people who inject drugs
Background: Hepatitis C virus (HCV) among young suburban people who inject drugs
(PWID) is a growing epidemic in the United States, yet little is known about the factors …
(PWID) is a growing epidemic in the United States, yet little is known about the factors …
[HTML][HTML] Association of co-occurring mental health problems with hepatitis C status among young people who inject drugs in rural New Mexico, 2016–2018
A Gupta, FM Shebl, Y Tong, K Wagner… - Addiction Science & …, 2022 - Springer
Background Injection drug use (IDU) remains the strongest risk factor for hepatitis C virus
(HCV) in the United States. HCV rates are increasing in rural areas among young adult …
(HCV) in the United States. HCV rates are increasing in rural areas among young adult …
[HTML][HTML] Risk factors for hepatitis C seropositivity among young people who inject drugs in New York City: implications for prevention
B Eckhardt, ER Winkelstein, MA Shu, MR Carden… - PLoS …, 2017 - journals.plos.org
Background Hepatitis C virus (HCV) infection remains a significant problem in the United
States, with people who inject drugs (PWID) disproportionately afflicted. Over the last …
States, with people who inject drugs (PWID) disproportionately afflicted. Over the last …
Risk factors for hepatitis C virus infection among street youths
É Roy, N Haley, P Leclerc, JF Boivin, L Cédras… - Cmaj, 2001 - Can Med Assoc
Background: The relative contributions to risk of hepatitis C virus (HCV) infection resulting
from unsafe sexual behaviours and exposures to blood (eg, tattooing, body piercing and …
from unsafe sexual behaviours and exposures to blood (eg, tattooing, body piercing and …
[HTML][HTML] Disparities in risk perception and low harm reduction services awareness, access, and utilization among young people with newly reported hepatitis C …
Background Newly reported hepatitis C virus (HCV) infections in California increased 50%
among people 15–29 years of age between 2014 and 2016. National estimates suggest this …
among people 15–29 years of age between 2014 and 2016. National estimates suggest this …
Understanding the context of risk practices among injecting drug users: Implications for hepatitis C prevention
SE Habib - Australian Journal of Social Issues, 2003 - Wiley Online Library
'Risk'is central to recent sociological studies of health and related behaviour, particularly in
discourses about HIV/AIDS and hepatitis C (HCV). While epidemiological survey …
discourses about HIV/AIDS and hepatitis C (HCV). While epidemiological survey …
Hepatitis C incidence—a comparison between injection and noninjection drug users in New York City
Hepatitis C virus (HCV) burdens injection drug users (IDUs) with prevalence estimated from
60–100% compared to around 5% among noninjection drug users (non-IDUs). We present …
60–100% compared to around 5% among noninjection drug users (non-IDUs). We present …